Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy
Jae H. Park, Martin S. Tallman
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
3
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cytotoxic Chemotherapy
100%
Acute Promyelocytic Leukemia
100%
Cure Rate
50%
Arsenic Trioxide
50%
Chemotherapy
25%
All-trans Retinoic Acid
25%
Treatment Regimen
25%
Acute Myeloid Leukemia
25%
Targeted Therapy
25%
Fatal Infection
25%
DNA Damage
25%
Management Strategy
25%
Anthracyclines
25%
Survival Rate
25%
Cardiomyopathy
25%
Treatment Failure
25%
Long-term Complications
25%
Drug Information
25%
Complete Remission
25%
Low Risk
25%
Initial Treatment
25%
High Response Rate
25%
Excellent Outcome
25%
Complete Cure
25%
Intermediate Risk
25%
Anthracycline-based Chemotherapy
25%
High Survival
25%
Hemorrhagic Disease
25%
Therapy-related Myelodysplastic Syndrome (t-MDS)
25%
Contemporary Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cytotoxic Chemotherapy
100%
Promyelocytic Leukemia
100%
Chemotherapy
50%
Arsenite
50%
Anthracycline
50%
Drug Information
25%
Retinoic Acid
25%
Remission
25%
Survival Rate
25%
Disease
25%
Acute Myeloid Leukemia
25%
Cardiomyopathy
25%
Myelodysplastic Syndrome
25%
Medicine and Dentistry
Acute Promyelocytic Leukemia
100%
Cytotoxic Chemotherapy
100%
Anthracycline
50%
Arsenic Trioxide
50%
Diseases
25%
Survival Rate
25%
Cardiomyopathy
25%
Acute Myeloid Leukemia
25%
Myelodysplastic Syndrome
25%
Tretinoin
25%
Targeted Therapy
25%